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Oxidation of low density lipoprotein by mesangial cells may
promote glomerular injury
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Oxidation of tow density tipoprotein by mesangial cells may promote
gtomerular injury. Low density lipoprotein (LDL) deposition and local
oxidation play a key role in the pathogenesis of atherosclerosis and may
likewise contribute to glomerular injury. These studies were designed to
determine whether cultured human mesangial cells oxidize homologous
LDL and to compare the effects of unmodified and oxidized lipoprotein
on cell proliferation, viability and eicosanoid production. Cell-mediated
lipoprotein oxidation was demonstrated and could be suppressed by
oxygen free radical scavengers and inhibitors of arachidonic acid
metabolism. When incubated with cells, oxidized LDL (Ox-LDL) at
concentrations up to and including 100 .tg/ml reduced 3H-thymidine
incorporation without causing cytotoxicity as assessed by lactate de-
hydrogenase release. Under the same conditions there was a concen-
tration-dependent increase in the synthesis of prostaglandins E2, 6-keto-
PGF1, and thromboxane B2. In contrast, unmodified LDL enhanced
DNA synthesis at concentrations less than 40 g/ml and had little effect
on eicosanoid production. These results demonstrate that exogenous
oxidized LDL inhibits mesangial cell proliferation and increases ei-
cosanoid synthesis. Unmodified lipoprotein can be directly oxidized by
these cells through mechanisms that involve generation of oxygen free
radicals.
Recent animal studies have suggested that lipids contribute to
renal injury and that correction of hyperlipidemia may slow the
progression of chronic renal failure [1, 2]. Histological analysis
of scarred glomeruli has revealed several features in common
with atherosclerotic lesions suggesting that both glomeruloscie-
rosis and atherosclerosis may share common pathogenic mech-
anisms [3]. This analogy is further strengthened by in vitro
studies demonstrating morphological and functional similarities
between vascular smooth muscle and glomerular mesangial
cells, both of which play a key role in these scarring processes
[4].
Accumulation of low density lipoprotein (LDL) has long been
recognized as an early event in the development of atheroscle-
rotic plaques [5]. LDL particles deposited in the arterial wall
appear to undergo local oxidation [6], a process that may be
mediated by endothelial cells, vascular smooth muscle cells and
macrophages [7, 8]. Oxidation of LDL could enhance the
development of the vascular lesions by a number of different
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mechanisms. In contrast to unmodified lipoprotein, Ox-LDL is
a chemoattractant for monocytes, induces expression of cell
adhesion molecules on endothelial cells and stimulates these
cells to produce monocyte chemoattractant proteins, thus po-
tentially promoting vascular inflammation [6, 9]. In addition
oxidized lipoprotein is more readily taken up by infiltrating
mononuclear cells, is less readily degraded than unmodified
lipoprotein and stimulates these cells to produce vasoactive
eicosanoids [6, 10]. Finally, oxidation renders LDL cytotoxic to
endothelial and smooth muscle cells in vitro [9].
In animal models of renal disease, lipid deposition and
mononuclear cell infiltration are recognized early features of
glomeruloscierosis and are exacerbated by high cholesterol
diets which promote glomerular injury [11, 12]. Analysis of
renal tissue from these animals has indicated that lipid accumu-
lation is particularly prominent in visceral epithelial cells and in
the mesangium where foam cells are frequently identified [11,
12]. Lipid deposits contain apoproteins usually associated with
very low density lipoprotein (VLDL) and LDL particles [13]. In
addition, Ox-LDL has been identified in the glomeruli of
cholesterol-fed nephrotic rats using specific monoclonal anti-
bodies [14]. Based on our understanding of the pathogenic
mechanisms involved in atherogenesis it has been proposed that
oxidative modification of LDL may contribute to glornerular
injury [1]. Thus Ox-LDL could promote a chronic inflammatory
reaction within the glomerulus, might directly injure glomerular
cells and might modify secretion of vasoactive mediators and
matrix components. Although there is no direct evidence to
support this hypothesis, in vivo studies have suggested that
LDL oxidation contributes to enhanced thromboxane produc-
tion and to renal vasoconstriction in cholesterol-fed animals [1,
15].
Previous in Vitro studies of glomerular cell-lipoprotein inter-
actions have demonstrated that mesangial cells show a biphasic
proliferative response when increasing amounts of LDL are
added to the incubation medium. Growth inhibition was ob-
served at higher lipoprotein concentrations which were cyto-
toxic to proliferating cells [16—18]. However, all but one of
these studies were based on a heterologous system in which rat
cells were exposed to human LDL and did not distinguish
between the effects of unmodified and oxidized lipoprotein.
When LDL was chemically oxidized and added to cultured rat
mesangial cells a cytotoxic effect could be demonstrated [19].
The following experiments were designed to determine whether
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human mesangial cells oxidize homologous LDL and if so, to
investigate the possible metabolic pathways involved in this
process. In addition, since oxidation of LDL might influence its
interactions with mesangial cells, the effects of unmodified and
subcytotoxic concentrations of oxidized lipoprotein on cell
proliferation, viability and eicosanoid synthesis were corn-
pared.
Methods
Glomerular cell culture and characterization
Human renal tissue was obtained from macroscopically nor-
mal areas of nephrectomy specimens containing well circum-
scribed renal tumors or from cadaver kidneys unsuitable for
transplantation. Glomeruli were separated by differential siev-
ing of cortical material, collagenase digested and plated. Incu-
bation medium comprised RPM! supplemented with 20% heat-
inactivated fetal calf serum, glutamine (300 jsglml), insulin
(5 p.glml) transferrin (5 gIml) and selenium (5 nglml). Dishes
were incubated at 37°C in a humidified atmosphere of 5% CO2
and 95% air. Stellate-shaped mesangial cells which predomi-
nated after six to eight days were passaged and outgrew other
cells types in prolonged culture. Epithelial cells were obtained
by trypsinizing early outgrowths and passing suspended cells
through a 90 pm sieve to remove whole glomeruli. These cells
were maintained in medium with a lower serum concentration
(10%) further supplemented with 0.4 sg/ml hydrocortisone. The
characterization of these two cell types has been described in
detail in earlier publications [20, 21]. Cells from passages 2 to 9
were plated in 2.0 cm2 microwells (Falcon Scientific Supplies,
London, UK) and grown to confluence. After certain experi-
ments cells were dissolved in 0.1 N NaOH and the cell protein
content of individual wells estimated using the method of
Bradford [221.
Isolation and oxidation of LDL
Plasma was collected from normal human volunteers into a
preservative cocktail to prevent oxidation and proteolytic deg-
radation [23]. LDL (density range 1.019 to 1.063 g/ml) was
isolated by sequential ultracentrifugation (Centrikon Tl065
ultracentrifuge with TFT 50.38 rotor) at 37,000 rpm for 20 hours
at 4°C using potassium bromide (KBr) for density adjustment.
The isolated lipoprotein was dialyzed against 0.15 M NaCl
containing 0.3 m ethylene diaminetetraacetic acid EDTA (pH
7.4) to remove KBr and subsequently against sodium car-
boxymethylcellulose (Aquacide II, Calbiochem Novabiochem
UK Ltd, Nottingham, UK) to concentrate. Samples were
passed through a 0.22 m filter (Millipore UK, Harrow, UK) to
sterilize and stored under nitrogen at 4°C. The purity of isolated
lipoproteins was assessed by chemical analysis and by deter-
mination of the apoprotein composition using sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). The
protein, triglyceride, cholesterol and phospholipid composition
of isolated LDL was in agreement with published data [24].
SDS-PAGE demonstrated a single apoprotein (apo B 100) band
suggesting minimal contamination with other lipoprotein parti-
cles.
LDL was oxidized in a cell-free system by incubation with
copper ions. Lipoprotein (200 jsglml) was suspended in 0.15 M
NaC1 (pH 7.4) and freshly prepared CuSO4 added to a final
concentration of 5 to 10 M. Following incubation for 24 hours
at 37°C, 25 M EDTA was added to prevent further oxidation.
Modified LDL was recovered by ultracentrifugation at a density
of 1.100 glml then dialyzed and concentrated as described
above. Native and oxidized lipoproteins were quantified by
measuring protein concentration using the Lowry method [25].
Oxidation of LDL was confirmed by measuring mobility on
agarose gel and by analysis of the thiobarbituric acid reactive
substance (TBARS) content of samples. To assess TBARS,
LDL (30 to 50 gIml) suspended in 0.9% saline was mixed
with 20% trichloroacetic acid and 0.67% thiobarbituric acid.
Samples were heated to 96°C for 60 minutes, cooled, centri-
fuged at 1500 g for 10 minutes and the absorbence of the
supernatant measured at a wavelength of 532 nm [26]. Alterna-
tively, samples were shaken vigorously with n-butanol, centri-
fuged at 1500 g for 10 minutes and the organic phase assayed
fluorometrically using excitation and emission wavelengths of
515 nm and 553 nm, respectively. Freshly diluted 1,1,3,3-
tetrarnethoxypropane, which yields malondialdehyde (MDA)
when exposed to thiobarbituric acid, was used as a standard
and results were expressed as MDA equivalents per mg LDL
protein. The TBARS content of LDL oxidized by incubation
with copper ions was consistently greater than 10 nM MDAImg
protein compared with less than 3 nM MDA/mg for unmodified
lipoprotein immediately after isolation. On agarose gel electro-
phoresis, oxidized LDL was shown to have greater cationic
charge than unmodified lipoprotein (Fig. 1). To check the
stability of stored unmodified LDL, samples were analyzed for
evidence of oxidation at regular intervals. Even eight weeks
after isolation, no increase in TBARS content or change in
electrophoretic mobility could be detected.
Mod/1cation of LDL by cells
LDL (200 tg/ml) was added to microwells containing conflu-
ent cells incubated in RPM! or to control wells containing
medium but no cells. After 24 hours, 25 sM EDTA was added
to prevent further oxidation and the media centrifuged at 1000 g
for 15 minutes at 4°C to remove detached cells. LDL oxidation
was determined by measuring TBARS content as described
above. Cell-specific oxidation was taken to be the difference in
TBARS values of recovered LDL incubated in wells with cells
and in wells without cells under otherwise identical experimen-
tal conditions. The mechanisms of cell-specific LDL oxidation
were investigated by addition of antioxidants including manni-
tol (1.25 to 5 mM), butylated hydroxytoluene (BHT, ito 25 sM)
superoxide dismutase (0.2 to 0.6 mg/ml), catalase (50 to 200
U/mI), /3-carotene (10 to 25 ILM), a cyclooxygenase inhibitor
(indornethacin, 10 to 25 sM) a lipoxygenase and monooxygen-
ase inhibitor (nordihydroguaiaretic acid, NDGA, I to 10 jzM)
and a competitive inhibitor of lipoxygenase, cyclooxygenase
and monooxygenase pathways of arachidonic acid metabolism
(eicosatetraynoic acid, ETYA, 10 to 25 sM).
Proliferation and cytotoxicity studies
Incubation media containing human LDL and Ox-LDL at a
range of different concentrations were prepared for these stud-
ies. Growth medium was rendered effectively lipid-free by
ultracentrifugation of FCS at 37,000 rpm for 24 hours at 4°C
using KBr at a density of 1.250 g/ml. Serum was then dialysed
extensively against buffer (see above) and sterilized by filtration
samples of cell conditioned medium were incubated in a mi-
crotitre plate with 20 d of reduced 4 mrvi /3-nicotinamide
adenine dinucleotide (NADH; Sigma Chemical Company,
Poole, UK) and 10 l of sodium pyruvate for 12 minutes at
25°C. Absorbence at 340 nm was assessed at one minute
intervals. LDH activity was determined from the rate of change
of optical density and expressed as a percentage of values
obtained from wells in which cells had been sonicated.
Eicosanoid synthesis
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Fig. 1. Electrophoretic mobility of unmodfled and chemically oxidized
LDL on agarose gel. LDL was incubated in 0.15 M NaCI with 5 M
CuSO4 for24 hours. Samples of lipoprotein (5 g protein) were applied
to the gel (0.7% agarose) in 33% glycerol, the gel run in 0.05 M sodium
barbital buffer (pH 8.6) and stained with coomassie blue. Lane 1 =
unmodified LDL; Lane 2 = chemically oxidized LDL.
through a 0.22 tm filter (Millipore UK), This modified FCS was
used in place of normal FCS to make lipoprotein-free incuba-
tion medium to which human LDL or Ox-LDL were added at
concentrations between 10 and 100 gIml. The TBARS content
of chemically oxidized LDL used for these experiments was 10
to 15 flM MDA/mg protein.
The rate of cell proliferation in the above lipoprotein-supple-
mented media was estimated by measuring incorporation of
3H-thymidine. After 48 hours preincubation in serum-free me-
dium, cells were grown in experimental media containing LDL
or Ox-LDL and 3H-thymidine (37 KBq/ml). Incorporation was
halted after 24 hours by washing cells six times with ice-cold
phosphate-buffered saline (PBS), and the cell layer was dis-
solved by addition of 0.5 N NaOH. Aliqouts of cell suspension
were counted for 3H activity in a p liquid scintillation counter.
Uptake of thymidine by cells grown in lipoprotein-supple-
mented media was expressed as a percentage of incorporation
by control cells grown in regular medium under identical
experimental conditions.
Cytotoxicity was assessed by measuring lactate dehydroge-
nase (LDH) released into cell-conditioned medium. Enzyme
concentrations were determined from the rate of oxidation of
nicotine adenine dinucleotide (measured as a change in optical
density) during LDH-catalyzed conversion of pyruvate to lac-
tate as previously described [27]. Briefly, triplicate 150 l
Cells growth-arrested in serum-free conditions for 48 hours
were incubated with 10 to 100 g/ml unmodified or chemically
oxidized LDL (TBARS content 10 to 15 flM MDA/mg protein)
for 24 hours at 37°C. Concentrations of PGE2 and of the stable
metabolites of PG!2 (6-keto-PGF1a) and thromboxane (TX) A2
(TXB2) in cell-conditioned media were measured by radioim-
munoassay using highly specific rabbit antibodies (Bioclinical
Services Ltd, Cardiff, UK). A 100 sl sample of medium was
mixed with anti-eicosanoid antibody, a known amount of radio-
labeled eicosanoid (Amersham International plc, Amersham,
UK) and a second goat anti-rabbit y-globulin antibody (Calbio-
chem Novabiochem UK Ltd) in buffer and incubated overnight
at 4°C. Bound and unbound ligands were separated by centrif-
ugation at 10,000 g for 30 minutes, the resulting pellet was
redissolved in 0.1 N NaOH, added to scintillation fluid and
counted in a /3 liquid scintillation counter. The unknown con-
centration of eicosanoid was calculated using standards in-
cluded in each assay. Cell protein content of each well was
estimated using the Bradford method and eicosanoid concen-
trations expressed as nglmg cell protein.
Statistical Analysis
Results are expressed as mean 1 standard deviation unless
otherwise indicated. Statistical analysis was performed using a
paired Students t-test or where stated by analysis of variance
(ANOVA).
Results
Lipoprotein oxidation by glomerular cells
Incubation of LDL in RPM! led to oxidation of particles even
in control wells which did not contain cells. After 24 hours at
37°C, the TBARS content of lipoprotein increased from <3 to
6.7 1.0 flM MDA/mg LDL protein, and there was a corre-
sponding change in electrophoretic mobility on agarose gel. In
wells containing mesangial cells, lipoprotein oxidation was
further enhanced as demonstrated by a higher TBARS value
(19.7 0.4 nM MDAImg LDL protein, P < 0.001 vs. control
wells; Fig. 2) and by a greater increase in electrophoretic
mobility (Fig. 3). Cell-specific oxidation (13.0 nt MDAImg cell
protein) thus accounted for 66.0% of the total TBARS content
of modified lipoprotein under these conditions. In contrast to
mesangial cells, glomerular epithelial cells did not oxidize LDL
(Fig. 2).
Inhibition of oxidation
The addition of a number of antioxidants inhibited cell-
mediated modification of lipoprotein particles (Fig. 4). Although
some of these compounds were effective over a range of
different concentrations, those concentrations that had the
greatest inhibitory effect are quoted below. Compared to no
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Fig. 2. TBARS content of LDL incubated with mesangial and epithe-
hal cells. LDL (200 &gIm1) was incubated for 24 hours in microwells
containing confluent glomerular cells (N = 4) or in control wells
containing medium but no cells (N = 4). The mean (SD) TBARS content
of recovered lipoprotein was measured as described in the text and is
expressed as malondialdehyde (MDA) equivalents corrected for the
protein content of the sample. Similar results were obtained in 2 other
identical experiments, Symbols are: (•) with cells; () without cells;
*D < 0.001. (adapted from [48] with permission)
inhibitor (100%), mannitol (a hydroxyl radical scavenger) al-
most completely protected LDL, reducing cell specific oxida-
tion to a mean (SD) of9.2% (8.8%) when added at a concentra-
tion of 5 mM (P < 0.01). Addition of 25 tM BHT (a non-specific
free oxygen radical scavenger) reduced cell-mediated LDL
oxidation to 20.8% (1.5%; P < 0.001) and superoxide dismutase
to 53.1% (3.0%; P < 0.01). Catalase tended to inhibit LDL
oxidation although this result did not reach statistical signifi-
cance, while /3-carotene (an endogenous carotenoid that binds
singlet oxygen species) was ineffective. These results suggest
that the generation of oxygen free radicals by mesangial cells
might contribute to oxidation. To determine whether arachi-
donic acid metabolism was a source of these molecules, a
variety of enzyme inhibitors were added to the incubation
medium. The lipoxygenase and monooxygenase inhibitor
NDGA reduced LDL modification by cells in a concentration-
dependent fashion. At 5.0 /.LM this inhibitor decreased cell-
specific oxidation to 1.8% (2.2%) of control (P < 0.001) and at
higher concentrations completely inhibited the ability of cells to
modify LDL. Inhibition of cyclooxygenase by indomethacin
(10 ,tLM) reduced cell-mediated oxidation of LDL to 63.6%
(0.9%; P < 0.01) and addition of the arachidonic acid analogue
ETYA (25 jsM) to 39.9% (6.3%; P < 0.01). Taken together these
findings indicate that the metabolism of arachidonic acid pro-
vides a source of oxygen radicals for cell-mediated LDL
oxidation.
Cell proliferation, viability and cytotoxicity
In four separate experiments, human mesangial cells showed
a biphasic proliferative response when an increasing concentra-
2
Fig. 3. Electrophoretic mobility of cell-modffied LDL on agarose gel.
LDL samples (5 g protein) recovered after 24 hours incubation with
mesangial cells were subject to electrophoresis on agarose gel as
described in Figure 1. Lane I, LDL incubated with mesangial cells;
Lane 2, LDL incubated in medium without cells; Lane 3, unmodified
LDL.
tion of unmodified human LDL was added to lipoprotein-
depleted incubation medium. Compared to control conditions
(no LDL), 3H-thymidine uptake was significantly enhanced at
20 pg/m1 LDL but was no different at higher concentrations
(Fig. 5). In contrast, at 20 pg/ml and above, Ox-LDL signifi-
cantly inhibited thymidine incorporation. While the addition of
20 g/ml of unmodified LDL increased mean (SD) 3H-thymidine
uptake to 116% (7.5%) compared to control conditions (100%, P
<0.05), Ox-LDL significantly inhibited incorporation to 93.5%
(3.9%) at an equivalent concentration (P < 0.05). At 100 jsg/ml
Ox-LDL suppressed thymidine uptake to 49.0% (20.0%; P <
0.05 vs. no LDL) but unmodified lipoprotein to only 75.3%
(13.9%) of control (P NS). Taking all concentrations into
account, oxidized LDL significantly reduced nucleic acid incor-
poration when compared to unmodified lipoprotein (P <0.05,
ANOVA). Measurement of LDH release confirmed that at
concentrations up to and including 100 pgIml, neither LDL or
Ox-LDL caused toxicity (Fig. 5). In the same four experiments,
cytotoxicity was only observed at Ox-LDL concentrations
greater than 100 jg!ml. Cells exposed to 200 jsg/ml of unmod-
ified or oxidized LDL released 17.1% (15.4%) and 43.9%
(13.4%) of total intracellular LDH respectively (P < 0.05).
Eicosanoid production
Cells preincubated in serum-free conditions for 48 hours did
not synthesize measurable concentrations of eicosanoids when
25
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Fig. 4. Effects of antioxidants and enzyme
inhibitors on LDL oxidation by mesangial
cells. The TBARS content of recovered LDL
was measured and values obtained from
control wells without cells subtracted from
values for corresponding wells with cells to
estimate cell-specific oxidation. Taking
oxidation in the absence of inhibitors to be
100%, each column represents the mean (SD)
TBARS content of LDL incubated with cells
in the presence of various antioxidants and
enzyme inhibitors as indicated (N = 4). The
following concentrations were used: Mannitol
5 mM, butylated hydroxytoluene (BHT) 25
LM, superoxide dismutase (SOD),0.4 mg/nil
Catalase 200 U/mI, 13-carotene 25 jsM
nordihydroguaiaretic acid (NDGA) 5.0 rM,
eicosatetraynoic acid (ETYA) 25 rM and
indomethacin 10 LM. Except for NDGA,
which completely inhibited cell-mediated LDL
oxidation above 5 sM, these concentrations
represent those found in earlier studies to
produce the maximal inhibitory effect. *
0.01, ** P < 0.001.
subsequently exposed to delipidated FCS. Addition of unmod-
ified LDL caused only a small non-significant increase in
production of POE2, 6-keto-PGF1 and TXB2 (Fig. 6). In
contrast, a marked concentration-dependent increase in the
production of all three eicosanoids was demonstrated when
chemically oxidized LDL was added to the incubation medium.
This effect was apparent even at concentrations as low as 40
jsg/ml. Cells exposed to 100 g/ml of Ox-LDL synthesized 210
45.0 ng/mg PGE2, 1060.0 235.0 ng/mg 6-keto-PGF1, and
46.4 15.8 ng/mg TXB2 compared with 9.9 2.8, 173.7 60.0
and 2.1 1.7 ng/mg, respectively, at an equivalent concentra-
tion of unmodified lipoprotein. The effects of unmodified and
Ox-LDL on prostaglandin and thromboxane production were
significantly different in the case of all three eicosanoids when
analyzed by ANOVA.
Having established that chemically oxidized LDL stimulated
eicosanoid production we repeated these experiments with
lipoprotein that had been oxidized by mesangial cells. LDL
exposed to mesangial cells for 24 hours was recovered from
conditioned medium by ultracentrifugation, added to cells
growth-arrested in microwells and incubated for a further 24
hours at 37°C. LDL incubated in microwells with medium but
without cells served as a control. In two similar experiments,
this cell-modified LDL stimulated mesangial cell PGE2 produc-
tion in a concentration-dependent manner as had been previ-
ously observed with chemically modified lipoprotein (Fig. 7).
LDL that had been incubated in medium without cells caused a
small but less marked increase in POE2 synthesis consistent
with the small increase in TBARS content and electrophoretic
mobility demonstrated in previous experiments.
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100
2
80
60
a)
U)v )
a)I0
-J
Fig. S. Effects of LDL and Ox-LDL on mesangial cell DNA synthesis
and viability. Incorporation of 3H-thymidine by cells exposed to vary-
ing concentrations of lipoprotein for 24 hours is expressed as a
percentage of uptake by cells grown in lipoprotein-free medium. LDH
released from cells exposed to lipoprotein is expressed as a percentage
of total intracellular LDH estimated by sonicating cells. Each point
represents the mean (SD) result derived from 4 experiments each
including quadruplicate wells. Symbols are: (——) LDL; (—0—) Ox-
LDL; * P < 0.05 vs. control.
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Discussion
These results demonstrate that cultured human mesangial
cells oxidize LDL and that unmodified and oxidized lipoprotein
particles have different effects on cell proliferation and ei-
cosanoid production. Such findings also imply that LDL depos-
ited in the glomerular mesangium may become oxidized and
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that this process could contribute to glomerular injury. In
contrast to mesangial cells, glomerular epithelial cells did not
oxidize LDL under identical experimental conditions. The
reason for this difference was not specifically addressed in these
studies, but may be related to quantitative differences in the
ability of these two cell types to produce reactive oxygen
metabolites. In a separate study, LDL has been shown to
stimulate production of superoxide anions by human mesangial
cells (S. Jones, personal communication), thus confirming pre-
viously published results [28]. In contrast, the ability of glomer-
ular epithelial cells to synthesize these highly reactive mole-
cules is less well established [29].
The mechanisms by which cultured vascular endothelial
cells, smooth muscle cells and macrophages oxidize LDL in
vitro have been investigated in detail. The involvement of
reactive oxygen metabolites is demonstrated by the fact that
both SOD and BHT effectively inhibit cell-mediated LDL
oxidation [30]. Although a variety of intracellular reactions may
provide a source of reactive oxygen species for LDL oxidation,
the lipoxygenase pathway which generates superoxide anions
during conversion of arachidonic acid to lipid hydroperoxides
Fig. 6. Eicosanoid production by mesangial cells exposed to LDL or
chemically oxidized LDL. Production of PGE2 (A) 6-keto-PGF1, (B)
and TXB, (C) by cells incubated with lipoproteins for 24 hours.
Points represent the mean (SD) eicosanoid concentration in
conditioned medium from 3 wells and each graph is representative of
at least 3 identical experiments. Symbols are: (—S—) LDL; (-0—) Ox-
LDL; * P < 0.05 (ANOVA). (adapted from [48] with permission)
appears to be particularly important in this respect. This is
demonstrated by the fact that cell-induced lipoprotein modifi-
cation can be mimicked in a cell-free system by incubating LDL
with lipoxygenase enzyme extracted from soybeans [31]. Using
lipoxygenase inhibitors it has been possible to demonstrate that
this pathway is the predominant mechanism responsible for
LDL oxidation by endothelial cells and macrophages [32, 33].
In addition, lipoxygenase mRNA and protein have been iden-
tified in association with Ox-LDL in macrophage-rich areas of
atherosclerotic lesions, suggesting that this enzyme may play an
important role in LDL oxidation in vivo [34]. Our studies
demonstrating that oxidation of LDL by mesangial cells was
inhibited by mannitol, superoxide dismutase and BHT suggest
that reactive oxygen metabolites are also involved in this
process. Although catalase tended to inhibit oxidation, this
result was not statistically significant when compared to con-
trol. To determine whether arachidonic acid metabolism was an
important source of reactive oxygen species, various inhibitors
were added during incubation studies. Of these compounds
NDGA (a lipoxygenase and monooxygenase inhibitor) was the
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Fig. 7. PGE2 production by mesangial cells exposed to cell-oxidized
LDL. Cells were incubated for 24 hours with unmodified LDL or with
LDL that had been preincubated with cells or in medium without cells
for 24 hours prior to experiments. Each point represents the mean
(range) PGE2 concentration in conditioned medium from 3 wells.
Results shown are from a representative experiment. Symbols are:
(——) unmodified LDL; (—C)—) cell-modified LDL; (—0—) medium-
modified LDL.
most effective, completely abolishing cell-specific LDL oxida-
tion at concentrations greater than 5 M. In addition, ETYA, an
analogue that blocks all three major pathways of arachidonic
acid metabolism also inhibited oxidation as did indomethacin.
Although both NDGA and ETYA have anti-oxidant effects
which are independent of their ability to block eicosanoid
synthesis, these results suggest that arachidonic acid metabo-
lism, and more specifically the lipoxygenase and cytochrome
P-450 pathways, contribute to LDL oxidation by mesangial
cells. Since cells were studied in the quiescent state and a
non-proliferative concentration of LDL was used, it would
appear that cell-mediated oxidation is independent of prolifer-
ation. Our findings are broadly consistent with those of previ-
ously reported experiments based on guinea pig mesangial cells
and a recent study that utilized human cells [18, 35].
Just as oxidation of LDL particles enhances their atheroge-
nicity, modification of lipoprotein deposited in the mesangium
may promote glomerular injury. Chemical changes to LDL may
reduce binding to apo B/E receptors but promote uncontrolled
lipoprotein uptake via scavenger receptors [36, 37]. Rat mesan-
gial cells have been shown to possess both types of receptor but
preferentially bind and internalize oxidized LDL in vitro [19,
38—40]. Studies in human mesangial cells have so far identified
apo BIE but not scavenger receptors, so it is not clear whether
lipoprotein oxidation would enhance LDL uptake [41]. Such
changes in receptor recognition would, however, promote lipid
accumulation in macrophages which frequently invade the
glomerular mesangium in the early stages of glomerular injury
[11]. Oxidation of LDL might promote this chronic inflamma-
tory process by up-regulating expression of adhesion molecules
and enhancing synthesis of chemotactic substances. LDL has
been shown to increase production of monocyte chemoattrac-
tant protein-i by human mesangial cells in culture, although the
effects of oxidized lipoprotein have not been reported. This
cytokine could play a key role in the recruitment of mononu-
clear cells into the mesangium [28].
Oxidation also modifies the effects of LDL on cell growth and
viability. While unmodified LDL may stimulate cellular prolif-
eration in vitro, oxidized lipoprotein is cytotoxic to a number of
different cell types including endothelial cells, vascular smooth
muscle cells and fibroblasts [9, 42]. Cells appear to be most
susceptible to injury by oxidized lipoprotein during DNA
synthesis (the S phase of the cell cycle) [42]. In keeping with
earlier studies based on rat tissue culture, our results demon-
strate enhanced thymidine incorporation by mesangial cells
when low concentrations of unmodified LDL (less than 50
jsglml) are added to the incubation medium [16, 17]. At higher
concentrations this lipoprotein tended to inhibit cell prolifera-
tion, possibly because auto-oxidation by the cells themselves
led to the appearance of Ox-LDL in the medium. A similar
biphasic response to increasing LDL concentration was noted
in a recent study which utilized human mesangial cells, al-
though proliferation was noted over a wider range of lipoprotein
concentrations [18]. In the present study Ox-LDL inhibited cell
division at concentrations less than 100 sg/ml but did not cause
detectable cell damage. However in contrast to unmodified
lipoprotein, higher concentrations of Ox-LDL enhanced LDH
release thus indicating cytotoxicity. These results are in keep-
ing with studies in which rat mesangial cells were injured by
human Ox-LDL added to the incubation medium [19]. A clear
distinction between the growth inhibitory and cytotoxic effects
of Ox-LDL has been noted by other investigators in fibroblast
cultures [42]. In addition, when the lipid components of Ox-
LDL have been separated by thin layer chromatography and
added individually to cultured rat mesangial cells, lysophos-
phatidylcholine has been identified as the major cytotoxic
component, although other fractions inhibited growth without
causing cell lysis [43]. Thus, local oxidation of LDL in the
mesangium could contribute to glomerular injury as a direct
result of growth inhibitory or cytotoxic effects.
Lipoproteins may also contribute to glomerular injury by
modifying eicosanoid production. In this respect, LDL oxida-
tion has been implicated as a mediator of renal vasoconstriction
associated with hypercholesterolemia in rats. In a recent study
the antioxidant drug, probucol, corrected the hemodynamic
abnormalities usually associated with a high cholesterol diet
[15]. Since this drug did not significantly reduce total plasma or
LDL cholesterol concentrations and since infusions of a throm-
boxane receptor antagonist had a similar effect, the authors
concluded that LDL oxidation in vivo initiates thromboxane-
mediated renal vasoconstriction. Studies in non-glomerular
cells have confirmed that lipoproteins may modulate production
of arachidonic acid metabolites in vitro. For example, uptake of
Ox-LDL by macrophages stimulates synthesis of PGE2, PGI2
and leukotriene C4 (LTC) while unmodified LDL has no effect
[10]. In smooth muscle cell cultures, unmodified lipoprotein
which had not been protected from oxidation stimulated pro-
duction of PGE2 and PGI2, although this effect was small when
compared to that of HDL added to the medium at comparable
2
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